Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Yvette Hendricks was born with sickle cell disease in 1961, a time when many patients would not have been expected to live much beyond their teenage years. Hendricks, however, spent a lifetime defying ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Organizers of the 47th Annual Sickle Cell Softball Tournament held a press conference this afternoon to announce details for ...

Rising sickle cell disease in children demands urgent awareness. Early diagnosis, modern therapies, and vigilant care can ...

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...

European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease.Covers ...

Until recently, a small team issued timely guidance on the types of contraception certain high-risk women should use.